123 related articles for article (PubMed ID: 8080272)
1. Molecular and cellular studies of hyaluronic acid-modified liposomes as bioadhesive carriers for topical drug delivery in wound healing.
Yerushalmi N; Arad A; Margalit R
Arch Biochem Biophys; 1994 Sep; 313(2):267-73. PubMed ID: 8080272
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid-modified bioadhesive liposomes as local drug depots: effects of cellular and fluid dynamics on liposome retention at target sites.
Yerushalmi N; Margalit R
Arch Biochem Biophys; 1998 Jan; 349(1):21-6. PubMed ID: 9439578
[TBL] [Abstract][Full Text] [Related]
3. Physicochemical evaluation of a stability-driven approach to drug entrapment in regular and in surface-modified liposomes.
Peer D; Margalit R
Arch Biochem Biophys; 2000 Nov; 383(2):185-90. PubMed ID: 11185552
[TBL] [Abstract][Full Text] [Related]
4. Bioadhesive, collagen-modified liposomes: molecular and cellular level studies on the kinetics of drug release and on binding to cell monolayers.
Yerushalmi N; Margalit R
Biochim Biophys Acta; 1994 Jan; 1189(1):13-20. PubMed ID: 8305454
[TBL] [Abstract][Full Text] [Related]
5. Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells.
Eliaz RE; Szoka FC
Cancer Res; 2001 Mar; 61(6):2592-601. PubMed ID: 11289136
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronic acid: evaluation as a potential delivery vehicle for vitronectin:growth factor complexes in wound healing applications.
Xie Y; Upton Z; Richards S; Rizzi SC; Leavesley DI
J Control Release; 2011 Aug; 153(3):225-32. PubMed ID: 21457738
[TBL] [Abstract][Full Text] [Related]
7. Preparation and in vivo evaluation of cationic elastic liposomes comprising highly skin-permeable growth factors combined with hyaluronic acid for enhanced diabetic wound-healing therapy.
Choi JU; Lee SW; Pangeni R; Byun Y; Yoon IS; Park JW
Acta Biomater; 2017 Jul; 57():197-215. PubMed ID: 28476587
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers.
He M; Zhao Z; Yin L; Tang C; Yin C
Int J Pharm; 2009 May; 373(1-2):165-73. PubMed ID: 19429302
[TBL] [Abstract][Full Text] [Related]
9. The liposomal formulation of doxorubicin.
Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
[TBL] [Abstract][Full Text] [Related]
10. Investigation of epidermal growth factor containing liposome formulation effects on burn wound healing.
Alemdaroğlu C; Degim Z; Celebi N; Sengezer M; Alömeroglu M; Nacar A
J Biomed Mater Res A; 2008 Apr; 85(1):271-83. PubMed ID: 17937411
[TBL] [Abstract][Full Text] [Related]
11. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.
Spagnou S; Miller AD; Keller M
Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effects of hyaluronate - epidermal growth factor conjugate patch on chronic wound healing.
Kim YS; Sung DK; Kong WH; Kim H; Hahn SK
Biomater Sci; 2018 May; 6(5):1020-1030. PubMed ID: 29616250
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronan-modified and regular multilamellar liposomes provide sub-cellular targeting to macrophages, without eliciting a pro-inflammatory response.
Glucksam-Galnoy Y; Zor T; Margalit R
J Control Release; 2012 Jun; 160(2):388-93. PubMed ID: 22019559
[TBL] [Abstract][Full Text] [Related]
14. Bioimaging for targeted delivery of hyaluronic Acid derivatives to the livers in cirrhotic mice using quantum dots.
Kim KS; Hur W; Park SJ; Hong SW; Choi JE; Goh EJ; Yoon SK; Hahn SK
ACS Nano; 2010 Jun; 4(6):3005-14. PubMed ID: 20518553
[TBL] [Abstract][Full Text] [Related]
15. Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies.
Gabizon A; Horowitz AT; Goren D; Tzemach D; Mandelbaum-Shavit F; Qazen MM; Zalipsky S
Bioconjug Chem; 1999; 10(2):289-98. PubMed ID: 10077479
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
Bhatia A; Kumar R; Katare OP
J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
[TBL] [Abstract][Full Text] [Related]
18. [The effect of ultrapure hyaluronic acid with different molecular weights on the healing of porcine full thickness skin wound].
Jia C; Chen B; Arnold F
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 1998 Jul; 12(4):197-200. PubMed ID: 10437065
[TBL] [Abstract][Full Text] [Related]
19. Prolonged release biodegradable vesicular carriers for rifampicin--formulation and kinetics of release.
Kamath MP; Shenoy BD; Tiwari SB; Karki R; Udupa N; Kotian M
Indian J Exp Biol; 2000 Feb; 38(2):113-8. PubMed ID: 11218826
[TBL] [Abstract][Full Text] [Related]
20. New formulation of vasoactive intestinal peptide using liposomes in hyaluronic acid gel for uveitis.
Lajavardi L; Camelo S; Agnely F; Luo W; Goldenberg B; Naud MC; Behar-Cohen F; de Kozak Y; Bochot A
J Control Release; 2009 Oct; 139(1):22-30. PubMed ID: 19481575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
